Items where authors include "Hall, PS"

Export as [feed] Atom [feed] RSS
Number of items: 20.

Article

Hall, PS, Cairns, DA orcid.org/0000-0002-2338-0179 and Seymour, MT orcid.org/0000-0002-2441-9629 (2021) Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population—Reply. JAMA Oncology, 7 (11). 1725. ISSN 2374-2437

Hall, PS, Swinson, D, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (32 more authors) (2021) Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial. JAMA oncology, 7 (6). pp. 869-877. ISSN 2374-2437

Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X

Smith, AF orcid.org/0000-0001-7709-1869, Shinkins, B orcid.org/0000-0001-5350-1018, Hall, PS et al. (2 more authors) (2019) Towards a framework for outcome-based analytical performance specifications: a methodology review of indirect methods for evaluating the impact of measurement uncertainty on clinical outcomes. Clinical Chemistry, 65 (11). pp. 1363-1374. ISSN 0009-9147

Hall, PS, Smith, A orcid.org/0000-0001-7709-1869, Hulme, C orcid.org/0000-0003-2077-0419 et al. (15 more authors) (2017) Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. Value in Health, 20 (10). pp. 1311-1318. ISSN 1098-3015

Smith, AF orcid.org/0000-0001-7709-1869, Hall, PS, Hulme, C orcid.org/0000-0003-2077-0419 et al. (5 more authors) (2017) Cost-effectiveness analysis of PET-CT guided management for locally advanced head and neck cancer. European Journal of Cancer, 85. pp. 6-14. ISSN 0959-8049

Martin, A orcid.org/0000-0002-2559-6483 and Hall, PS (2017) Accurate Measurement of Financial Toxicity Is a Prerequisite to Finding a Remedy. Breast Care, 12. pp. 78-80. ISSN 1661-3791

Hall, PS, Lord, SR, Collinson, M et al. (12 more authors) (2017) A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). British Journal of Cancer, 116. pp. 472-478. ISSN 0007-0920

Johnson, OA, Hall, PS and Hulme, C orcid.org/0000-0003-2077-0419 (2016) NETIMIS: Dynamic Simulation of Health Economics Outcomes Using Big Data. PharmacoEconomics, 34 (2). pp. 107-114. ISSN 1170-7690

Afshar, M, Hamilton, P, Seligmann, J et al. (5 more authors) (2015) Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)? Cancer Investigation, 33 (8). ISSN 0735-7907

Marti, J, Hall, PS, Hamilton, P et al. (5 more authors) (2015) The economic burden of cancer in the UK: a study of survivors treated with curative intent. Psycho-Oncology. ISSN 1057-9249

Hall, PS, Hamilton, P, Hulme, CT et al. (9 more authors) (2015) Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data. British Journal of Cancer, 112. 948 - 956. ISSN 0007-0920

Hall, PS, Edlin, R, Kharroubi, S et al. (2 more authors) (2012) Expected net present value of sample information: from burden to investment. Medical Decision Making, 32 (3). E11 - E21. ISSN 0272-989X

Hall, PS, McCabe, C, Stein, RC et al. (1 more author) (2012) Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer. Journal of the National Cancer Institute, 104 (1). 56 - 66. ISSN 0027-8874

Monograph

Hall, PS, Mitchell, ED orcid.org/0000-0002-2833-1632, Smith, AF orcid.org/0000-0001-7709-1869 et al. (9 more authors) (2018) The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Report. NIHR Journals Library , Health Technology Assessment, Volume 22, Issue 32. ISSN 1366-5278

Conference or Workshop Item

Stein, RC, Makris, A, MacPherson, IR et al. (17 more authors) (2021) Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population. In: 2021 ASCO Annual Meeting, 04-08 Jun 2021, Virtual.

Proceedings Paper

Swinson, D, Hingorani, M, Stokes, Z et al. (15 more authors) (2019) Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology , p. 4051.

Hall, PS, Swinson, D, Waters, JS et al. (17 more authors) (2019) Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology .

Handforth, C, Hall, PS, Marshall, HC et al. (3 more authors) (2013) Overall treatment utility: a novel outcome measure reflecting the balance of benefits and harms from cancer therapy. In: European Journal of Cancer. European Cancer Congress, 2013, Amsterdam, The Netherlands. Elsevier , S346 - S346.

Handforth, C, Hall, PS, Marshall, HC et al. (3 more authors) (2013) The feasibility of using comprehensive geriatric assessment in frail or elderly patients with advanced gastric or oesophageal cancer. In: European Journal of Cancer. European Cancer Congress 2013, 2013, Amsterdam, The Netherlands. Elsevier , S348 - S348.

This list was generated on Sat Mar 23 20:23:59 2024 GMT.